Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Dr Reddys Laboratories ADR repsg 1 Ord Shs RDY

Healthcare
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The... see more

Recent & Breaking News (NYSE:RDY)

Dr. Reddy's Announces the Launch of MEMANTINE HYDROCHLORIDE TABLETS, USP

Business Wire July 13, 2015

Dr. Reddy's Unveils New Corporate Brand Identity

Business Wire July 1, 2015

Dr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-F

Business Wire June 18, 2015

Dr. Reddy's Q4 & FY15 Financial Results

Business Wire May 12, 2015

Dr. Reddy's to Release Q4 and Full Year FY15 Results on May 12, 2015

Business Wire April 29, 2015

Curis Presents Preclinical Data on CUDC-427 at AACR Annual Meeting

GlobeNewswire April 22, 2015

Curis Announces Presentation of Data From CUDC-427 and IRAK-4 Programs at AACR Annual Meeting

GlobeNewswire April 14, 2015

Dr. Reddy's Laboratories and Its Subsidiary Promius PharmaTM Announce the Filing of Three NDAs With the USFDA

Business Wire April 7, 2015

Taxus Cardium Announces Agreement With Dr. Reddy's Laboratories To Co-Develop, Market & Sell Generx Angiogenic Microvascular Gene Therapy In Certain International Markets

PR Newswire April 7, 2015

Dr. Reddy's Laboratories to Acquire Select Portfolio of the Established Products Business of UCB in India

Business Wire April 1, 2015

Dr. Reddy's Q3 and 9 Months FY15 Financial Results

Business Wire January 29, 2015

Dr. Reddy's to Release Q3 FY15 Results on January 29, 2015

Business Wire January 22, 2015

Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-Oncology and Precision Oncology Targets

GlobeNewswire January 21, 2015

Dr. Reddy's Laboratories Closes the Acquisition of Habitrol® Brand from Novartis

Business Wire December 19, 2014

Dr. Reddy's Announces the Launch of Valganciclovir Tablets, USP

Business Wire December 16, 2014

Dr. Reddy's Announces the Launch of Docetaxel Injection USP

Business Wire November 24, 2014

Dr. Reddy's Announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets

Business Wire November 20, 2014

Dr. Reddy's Q2 and H1 FY15 Financial Results

Business Wire October 29, 2014

Dr. Reddy's Announces the Launch of Sirolimus Tablets, 1 mg and 2 mg

Business Wire October 28, 2014

Dr. Reddy's to Release Q2 FY15 Results on October 29, 2014

Business Wire October 17, 2014